Bayer HealthCare Consolidating All East Coast Business in New Jersey
04/05/2011
"We are very excited about the prospect of having a new site and facility that can house East Coast-based Bayer HealthCare employees from every division and function under one roof," said Mark Trudeau, president and CEO, Bayer HealthCare Pharmaceuticals Inc., Bayer HealthCare LLC USA, and chair of the company's U.S. East Coast Site Search Committee. "New Jersey is home to many biopharmaceutical and healthcare companies, and we look forward to benefiting from the many resources and opportunities available to us in the state."
Bayer currently has facilities in Wayne and Montville. It is considering several locations near its current sites for a consolidated headquarters. The company expects to conduct initial moves at the end of the year or early 2012, continuing through the end of 2013. Of the 500 slated new jobs, 300 will originate from employee relocations from other Bayer sites, while 200 positions will be newly created.
Fifteen of the world's 25 largest pharmaceutical companies call New Jersey home. Bayer produces some of the best-known pharmaceuticals, such as Aspirin, Aleve, and Alka Seltzer, among other drugs.
Project Announcements
AESC Expands Florence, South Carolina, Operations
03/28/2024
Alticor Expands Ada Township, Michigan, Operations
03/27/2024
Eastman Plans Longview, Texas, Production Operations
03/27/2024
DHL Supply Chain-Vantage Data Centers NV11 Plan Nevada Operations
03/26/2024
Big Jet Expands Pittsburgh, Pennsylvania, Operations
03/26/2024
Landmark Ceramics UST Expands Mt. Pleasant, Tennessee, Operations
03/25/2024
Most Read
-
2023's Leading Metro Locations: Hotspots of Economic Growth
Q4 2023
-
2023 Top States for Doing Business Meet the Needs of Site Selectors
Q3 2023
-
The Logistics Analysis That Drives Industrial Site Selection
Q4 2023
-
Manufacturing Momentum Is Building
Q1 2024
-
Technology’s Influence on Workforce Development
Workforce Q4 2023
-
37th Annual Corporate Survey: Economic Pressures Exerting Greatest Effect on Decision-Makers
Q1 2023
-
Industry in the Era of the Electron
Q1 2024